Glucagon-Like Peptide-2 in the Control of Gastrointestinal Motility: Physiological Implications

被引:10
|
作者
Baccari, Maria Caterina [1 ]
Vannucchi, Maria Giuliana
Idrizaj, Eglantina [1 ]
机构
[1] Univ Florence, Sect Physiol Sci, Dept Expt & Clin Med, Viale GB Morgagni 63, I-50134 Florence, Italy
关键词
Glucagon-like peptide-2; acetylcholine; gastrointestinal motility; neuromodulation; nitric oxide; substance P; vasoactive intestinal peptide; VASOACTIVE-INTESTINAL-PEPTIDE; GLP-2 RECEPTOR EXPRESSION; NITRIC-OXIDE; ENTERIC NEURONS; LIPID ABSORPTION; IN-VIVO; RELAXIN; LOCALIZATION; NO; NEUROTRANSMISSION;
D O I
10.2174/1389203723666220217142935
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucagon-Like Peptide-2 (GLP-2) is a pleiotropic hormone that plays several roles in different organs and tissues, so being involved in many physiological processes. Among these, it regulates gastrointestinal (GI) tract function binding to a specific G-protein coupled receptor (GLP-2R). Of note, GLP-2R is widely expressed in different cells of the GI tract, including excitatory and inhibitory neurons of the enteric nervous system. In the gut, GLP-2 has been reported to play numerous actions, among which the modulation of motility. Nevertheless, most of the GLP-2 effects and its role in physiological processes are still debated. The aim of this minireview is to summarize the data present in the literature on the control of GI motility by GLP-2, the mechanism through which it occurs, and to discuss the physiological implications of such effects. A better understanding of the role of GLP-2 on GI motor responses may be of importance for the development of new therapeutic approaches in GI dysmotility.
引用
收藏
页码:61 / 69
页数:9
相关论文
共 50 条
  • [31] The effects of glucagon-like peptide-2 on peripheral blood vessels
    Tsuneoka, Yayoi
    Nishimura, Tsubasa
    Masuhuchi, Ryotaro
    Oka, Jun-Ichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S202 - S202
  • [32] Biologic properties and therapeutic potential of glucagon-like peptide-2
    Drucker, DJ
    Boushey, RP
    Wang, F
    Hill, ME
    Brubaker, PL
    Yusta, B
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1999, 23 (05) : S98 - S100
  • [33] Glucagon-like peptide-2: Update of the recent clinical trials
    Jeppesen, PB
    GASTROENTEROLOGY, 2006, 130 (02) : S127 - S131
  • [34] The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis
    Guan, Xinfu
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2014, 307 (06) : R585 - R596
  • [35] A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro
    Lambeir, AM
    Proost, P
    Scharpé, S
    De Meester, I
    BIOCHEMICAL PHARMACOLOGY, 2002, 64 (12) : 1753 - 1756
  • [36] Evaluation of the relationship between plasma glucagon-like peptide-2 and gastrointestinal dysbiosis in canine chronic enteropathies
    Voudren, Caylie D.
    Mayhue, Erin J.
    Riehm, Michelle D.
    Jugan, Maria C.
    PLOS ONE, 2024, 19 (06):
  • [37] Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome
    Yazbeck, Roger
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (06) : 798 - 809
  • [38] Glucagon-like peptide-2 increases mesenteric blood flow in humans
    Bremholm, Lasse
    Hornum, Mads
    Henriksen, Birthe Merete
    Larsen, Steen
    Holst, Jens Juul
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (03) : 314 - 319
  • [39] Glucagon-like peptide-2 and intestinal adaptation: An historical and clinical perspective
    Dowling, RH
    JOURNAL OF NUTRITION, 2003, 133 (11): : 3703 - 3707
  • [40] Glucagon-Like Peptide-2 Regulates Release of Chylomicrons From the Intestine
    Dash, Satya
    Xiao, Changting
    Morgantini, Cecilia
    Connelly, Philip W.
    Patterson, Bruce W.
    Lewis, Gary F.
    GASTROENTEROLOGY, 2014, 147 (06) : 1275 - +